The rise in type 2 diabetes cases globally presents opportunities for growth in the market for GLP-1 drugs like Ozempic and ...
The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least ...
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...
SAHPRA cautions the public to not purchase and/or consume such products as their safety, efficacy, and quality have not been ...
The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...
Sahpra warns against counterfeit GLP-1 products like Ozempic, citing health risks. Only registered products should be used; ...